Establishment and validation of a prognostic signature for lung adenocarcinoma based on metabolism‐related genes

Abstract

We established a prognostic signature based on MRGs for LUAD and validated the performance of the model, which may provide a promising tool for the diagnosis, individualized immuno-/chemotherapeutic strategies and prognosis in patients with LUAD.